Platelet GPIIb/IIIa antagonists: how safe is this antithrombotic approach?

Am J Med. 1994 Mar;96(3):300. doi: 10.1016/0002-9343(94)90159-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / therapeutic use
  • Eptifibatide
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Peptides / therapeutic use
  • Platelet Membrane Glycoproteins / antagonists & inhibitors*
  • Thromboembolism / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Peptides
  • Platelet Membrane Glycoproteins
  • Eptifibatide
  • Abciximab